Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New inhibitors of PDE4, MMP and/or TNF-alpha discovered at Celgene

Nov. 8, 2004

New anticancer and immunostimulant agent isolated from plants by Japanese team

Nov. 8, 2004

Femara approved for post-tamoxifen treatment of early breast cancer

Nov. 5, 2004

ChemGenex plans phase II study of Quinamed in prostate cancer

Nov. 5, 2004

Second stage of CoFactor phase II study given green light

Nov. 5, 2004

MediGene concludes license agreement for cancer-killing herpes simplex viruses

Nov. 5, 2004

Velcade designated fast track drug for relapsed & refractory mantle cell lymphoma

Nov. 5, 2004

KI-105, a novel HSGAG-mimetic compound

Nov. 5, 2004

Reata Discovery licenses novel anticancer compounds

Nov. 4, 2004

Development of novel topoisomerase inhibitors for solid tumor therapy

Nov. 4, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...